ImmuLogic Pharmaceutical Corp. (Abridged) Harvard Case Solution & Analysis

ImmuLogic Pharmaceutical Corporation, the development stage biotechnology company, is considering IPO of common stock. Studies and the problem of high-tech start-ups in these cases. Problems associated with the "windows" for the public offering of shares will be allocated. "Hide
by Josh Lerner Source: Harvard Business School 25 pages.

immulogic pharmaceutical corporation case solution

immulogic pharmaceutical corporation case solution

Publication Date: December 9, 1992. Prod. #: 293087-PDF-ENG

Other Similar Case Solutions like

ImmuLogic Pharmaceutical Corp. (Abridged)

Share This